Clinical Trial Update: LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for lanreotide in metastatic pheochromocytoma and paraganglioma (LAMPARA); trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma
• Pheochromocytoma

Drugs mentioned

• Lanreotide (lanreotide)

Snippet

Sponsor: Antonio Fojo | Conditions: Paraganglioma, Pheochromocytoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING